LUXLAVIE
DEAD

Serial Number

79333480

Owner

Galderma Holding SA

Attorney

Camille M. Miller

Filing Date

Nov 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LUXLAVIE Trademark

Serial Number: 79333480

LUXLAVIE is a trademark filed by Galderma Holding SA on November 29, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Galderma Holding SA (96 trademarks)

Zählerweg 10

Entity Type: 33

Trademark Details

Filing Date

November 29, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations and substances for use in dermatology; injectable pharmaceutical products; injectable dermal fillers; pharmaceutical preparations and substances for use in skin care; muscle relaxants; medicinal preparations; medical preparations consisting of a dermatological preparation, individually or in a set, including, but not exclusively, pre-filled syringes and vials, for filling lines, wrinkles, scars, lips, for tightening the face and body contouring and for rejuvenating the skin; pharmaceutical preparations for use in non-surgical restorative and beauty care treatments and in aesthetic dermatology; synthetic injectable material for use in the treatment of fine lines and wrinkles and for rejuvenating the skin

Cosmetic preparations consisting of non-medicated gel and liquids for filling lines, wrinkles, scars, lips, for tightening the face and body and for rejuvenating the skin; skin care products; cosmetics for the treatment of wrinkled skin; skin care preparations for removing wrinkles; perfumery; cosmetics; non-medicated sun care preparations; essential oils for personal use; hair shampoos and conditioners; non-medicated skin care preparations, namely, creams, milks, lotions, gels, cleansers, moisturizers, serums and powders for the face, the body and the hands

Medical devices, namely, synthetic implants in gel form sold individually or in a set; medical devices, namely, synthetic implants in gel form for treating lines, wrinkles, scars, lips, for tightening the face and body and for rejuvenating the skin; injection syringes; injection devices for pharmaceutical products

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 5, 2025 LIMN
NEW REPRESENTATIVE AT IB RECEIVED
Dec 27, 2024 NREP
LIMITATION OF GOODS RECEIVED FROM IB
Nov 15, 2024 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 11, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 20, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 20, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 6, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 19, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 19, 2023 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 19, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 19, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 19, 2023 ABN2
NEW REPRESENTATIVE AT IB RECEIVED
Mar 18, 2023 NREP
REFUSAL PROCESSED BY IB
Nov 27, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 15, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 14, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2022 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 20, 2022 ADCH
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 31, 2022 AMPX
ASSIGNED TO LIE
Mar 29, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 25, 2022 PARI
APPLICATION FILING RECEIPT MAILED
Feb 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 17, 2022 REPR